UB Paderborn / Katalog / Suche / in CDI

Immune dysfunction in cirrhosis

World journal of gastroenterology : WJG, 2014-03, Vol.20 (10), p.2564-2577

Sipeki, Nora

2014

Link zum Volltext

Verfügbarkeit prüfen

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

PloS one, 2018-03, Vol.13 (3), p.e0194166-e0194166

2018

Link zum Volltext

Verfügbarkeit prüfen

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

BMC gastroenterology, 2021-03, Vol.21 (1), p.94-94, Article 94

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential risks and treatment options for colonic diverticular disease Novelties based on international guidelines

Orvosi hetilap, 2022-04, Vol.163 (16), p.614

2022

Link zum Volltext

Verfügbarkeit prüfen

Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies

World journal of gastroenterology : WJG, 2023-11, Vol.29 (42), p.5728-5750

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: Computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases

Clinica chimica acta, 2020-12, Vol.511, p.117-124

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality

Clinics and research in hepatology and gastroenterology, 2021-09, Vol.45 (5), p.101579-101579, Article 101579

2021

Link zum Volltext

Verfügbarkeit prüfen

Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections

Liver international, 2017-07, Vol.37 (7), p.1023-1031

2017

Link zum Volltext

Verfügbarkeit prüfen

Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

Clinical gastroenterology and hepatology, 2020-06, Vol.18 (7), p.1609-1617.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection

Liver international, 2016-11, Vol.36 (11), p.1628-1638

2016

Link zum Volltext

Verfügbarkeit prüfen

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Scientific reports, 2018-01, Vol.8 (1), p.399-399, Article 399

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease

Journal of Crohn's and colitis, 2019-07, Vol.13 (7), p.894-904

2019

Link zum Volltext

Verfügbarkeit prüfen

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation

Liver international, 2020-09, Vol.40 (9), p.2164-2171

2020

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis

Journal of hepatology, 2013-09, Vol.59 (3), p.457-466

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease

World journal of gastroenterology : WJG, 2015-06, Vol.21 (22), p.6952-6964

2015

Link zum Volltext

Verfügbarkeit prüfen

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]

Journal of Crohn's and colitis, 2015-08, Vol.9 (8), p.659-668

2015

Link zum Volltext

Verfügbarkeit prüfen

Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection

Liver international, 2016-11, Vol.36 (11), p.1628-1638

2016

Link zum Volltext

Verfügbarkeit prüfen

Su1836 Significance of Serological Markers in the Disease Course of Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S566-S566

2016

Link zum Volltext

Verfügbarkeit prüfen

Su1272 Presence of Anti-MZGP2 IgG and IgA Antibodies Assessed by 2 Different ELISA Assays Is Associated With Younger Age at Onset, Stricturing Disease Behavior, Need for Surgery and ASCA/Anti-OMP Plus™ Positivity in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-457-S-458

2015

Link zum Volltext

Verfügbarkeit prüfen

Su1271 Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-457-S-457

2015

Link zum Volltext

Verfügbarkeit prüfen

Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel Diseases; Is It Associated With a Change in the Disease Course?

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-242-S-243

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease

Journal of Crohn's and colitis, 2015-10, Vol.9 (10), p.891-898

2015

Link zum Volltext

Verfügbarkeit prüfen

OS-017-YI - Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Journal of hepatology, 2023-06, Vol.78, p.S25-S25

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Journal of hepatology, 2023-06, Vol.78, p.S25

2023

Link zum Volltext

Verfügbarkeit prüfen

Results of the prospective multicentre European R-LIVER registry reveal the unmet clinical needs of autoimmune hepatitis

Journal of hepatology, 2023-06, Vol.78, p.S45-S46

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Immune dysfunction in cirrhosis

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

Potential risks and treatment options for colonic diverticular disease Novelties based on international guidelines

Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies

Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: Computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases

Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality

Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections

Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn’s Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]

Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection

Su1836 Significance of Serological Markers in the Disease Course of Ulcerative Colitis

Su1272 Presence of Anti-MZGP2 IgG and IgA Antibodies Assessed by 2 Different ELISA Assays Is Associated With Younger Age at Onset, Stricturing Disease Behavior, Need for Surgery and ASCA/Anti-OMP Plus™ Positivity in Crohn's Disease

Su1271 Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients With Crohn's Disease

Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel Diseases; Is It Associated With a Change in the Disease Course?

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease

OS-017-YI - Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation

Results of the prospective multicentre European R-LIVER registry reveal the unmet clinical needs of autoimmune hepatitis

Suchergebnisse filtern